Article Text

PDF

GW23-e1067
THE VALUE OF CLOPIDOGREL TO ACUTE NON-ST ELEVATION MYOCARDIAL INFARCTION
  1. Jing Xiaoli,
  2. Cui Ximei,
  3. Li Hui,
  4. Jing Xiaoli
  1. The First Affiliated Hospital of Sun Yat-Sen University

    Abstract

    Objectives To observe and evaluate the clinical efficacy and safety of clopidogrel on acute non-ST elevation myocardial infarction (NSTEMI) .

    Methods 30 patients with acute NSTEMI in the control group were treated with Low Molecular Heparin, Aspirin and other anti-anginal drugs. Another 30 patients with acute NSTEMI were treated with Low Molecular Heparin, Aspirin combined with Clopidogrel, which the initial dose is 300 mg and followed 75 mg/d for 2 weeks in treatment group.

    Results Compared with the control group, the recurrence rate of cardiac angina was significantly reduced in the treatment group (p<0.05). Clinical symptoms and the depression of ST segment in electrocardiograph were improved apparently (p<0.05), and there was little influence on the index of blood clotting (p>0.05) .

    Conclusions The treatment of clopidogrel combined with the traditional anticoagulant drugs would be more effective and safe to NSTEMI.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.